結(jié)核分枝桿菌CarD蛋白結(jié)構(gòu)與功能的生物信息學(xué)分析
[Abstract]:Objective to predict the structure and function of Mycobacterium tuberculosis CarD protein by using biological information analysis software. Methods the sequence of H37Rv carD gene of Mycobacterium tuberculosis was compared with the similar sequence of GenBank by Blast tool in NCBI, and the N-J evolutionary tree was constructed by using MEGA 6.06 software. The amino acid sequences of Mycobacterium tuberculosis (H37Rv CarD) and Mycobacterium tuberculosis (CarD) with high homology were analyzed by ClustalX 2.1 software. Go to ExPASy website, use ProtParam tools to analyze the physical and chemical properties of CarD protein, use ProtScale to analyze protein hydrophobicity, use SignalP 4.1Server to predict protein signal peptide, use TMHMM Server v. 2.0 and TMPred to predict protein transmembrane helical region. SOPMA was used to predict protein secondary structure and SWISS-MODEL was used to model protein tertiary structure homology. Protein phosphorylation sites were predicted by NetPhos 3.1Server and conserved domains of CarD proteins were predicted by CDD tools in NCBI. Results the similarity of carD gene sequence of Mycobacterium was 100, and the evolutionary relationship was close. H37Rv and Mycobacterium vole originated from the same species and had high homology. The CarD molecule was highly conserved, stable, hydrophilic protein and no transmembrane region. There are four serine phosphorylation sites in the protein sequence without signal peptide. The secondary structure is 偽 -helix, and the tertiary structure homologous modeling is successful. CarD protein is a transcription regulator binding to RNA polymerase and belongs to the CarD/CdnL/TRCF family. Conclusion CarD protein is a RNA polymerase binding protein that regulates transcription and controls the growth of Mycobacterium tuberculosis. This protein sequence is conservative and stable, and it is a potential new target for tuberculosis treatment.
【作者單位】: 濰坊醫(yī)學(xué)院醫(yī)學(xué)檢驗(yàn)學(xué)系;濰坊醫(yī)學(xué)院臨床醫(yī)學(xué)院病原生物學(xué)教研室;
【基金】:國(guó)家自然科學(xué)基金項(xiàng)目(No.30972639) 山東省自然科學(xué)基金項(xiàng)目(No.ZR2016HM09)
【分類號(hào)】:R378.911
【參考文獻(xiàn)】
相關(guān)期刊論文 前7條
1 路曉紅;付玉榮;伊正君;;結(jié)核分枝桿菌MT3876蛋白的生物信息學(xué)分析[J];中國(guó)病原生物學(xué)雜志;2016年04期
2 趙娜;王繼春;;結(jié)核分枝桿菌耐藥機(jī)制的研究進(jìn)展[J];中國(guó)病原生物學(xué)雜志;2016年02期
3 張波;伊正君;付玉榮;劉花香;;分枝桿菌感染特征與結(jié)核分枝桿菌耐藥性分析[J];中國(guó)病原生物學(xué)雜志;2015年08期
4 郭玲玲;張曉磊;張進(jìn)順;賈曉暉;姜文靜;王春苗;劉楠;朱曉波;;剛地弓形蟲(chóng)ROP18基因的克隆及生物信息學(xué)分析[J];中國(guó)病原生物學(xué)雜志;2015年05期
5 宋娜;李光華;黃琪;孔聰;王洪海;徐穎;;針對(duì)潛伏結(jié)核感染的A39 DNA疫苗構(gòu)建及其免疫原性研究[J];微生物與感染;2015年01期
6 吳港;王金輝;張維;林敏;陳明;張?jiān)迫A;;細(xì)菌轉(zhuǎn)錄調(diào)控蛋白CarD的研究進(jìn)展[J];中國(guó)農(nóng)業(yè)科技導(dǎo)報(bào);2014年03期
7 劉云霞;張萬(wàn)江;;結(jié)核分枝桿菌與巨噬細(xì)胞相互作用的研究進(jìn)展[J];中國(guó)細(xì)胞生物學(xué)學(xué)報(bào);2012年06期
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 曹汴川;黃U,
本文編號(hào):2332837
本文鏈接:http://sikaile.net/xiyixuelunwen/2332837.html